FR2092649A1 - Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid - Google Patents

Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid

Info

Publication number
FR2092649A1
FR2092649A1 FR7020506A FR7020506A FR2092649A1 FR 2092649 A1 FR2092649 A1 FR 2092649A1 FR 7020506 A FR7020506 A FR 7020506A FR 7020506 A FR7020506 A FR 7020506A FR 2092649 A1 FR2092649 A1 FR 2092649A1
Authority
FR
France
Prior art keywords
thiomalate
acid
compsn
thiamine
ascorbic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7020506A
Other languages
French (fr)
Other versions
FR2092649B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7020506A priority Critical patent/FR2092649A1/en
Publication of FR2092649A1 publication Critical patent/FR2092649A1/en
Application granted granted Critical
Publication of FR2092649B1 publication Critical patent/FR2092649B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Antirheumatic compsn. comprises magnesium thiomalate, thiamine hydrochloride, acetylsalicylic acid and ascorbic acid for oral administration. 6 Tablets contg. neutral magnesium thiomalate 100 mg, thiamine hydrochloride 50 mg acetylsalicylic acid 330 mg and ascorbic acid 50 mg were given daily for from 4 to 10 days to three patients with rheumatic disorders. Distinct improvement of symptoms was noted and tolerance was good.
FR7020506A 1970-06-04 1970-06-04 Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid Granted FR2092649A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7020506A FR2092649A1 (en) 1970-06-04 1970-06-04 Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7020506A FR2092649A1 (en) 1970-06-04 1970-06-04 Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid

Publications (2)

Publication Number Publication Date
FR2092649A1 true FR2092649A1 (en) 1972-01-28
FR2092649B1 FR2092649B1 (en) 1973-07-13

Family

ID=9056669

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7020506A Granted FR2092649A1 (en) 1970-06-04 1970-06-04 Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid

Country Status (1)

Country Link
FR (1) FR2092649A1 (en)

Also Published As

Publication number Publication date
FR2092649B1 (en) 1973-07-13

Similar Documents

Publication Publication Date Title
CA977680A (en) Orally administrable drug dosage form with delayed release
ES403435A1 (en) Slow release pharmaceutical compositions
GB1380171A (en) Medicinal tablets
BE800695A (en) PHARMACEUTICAL PREPARATIONS TO BE ADMINISTERED ORALLY CONTAINING AGGLUTININ
ES370058A1 (en) Antibiotic compositions
FR2092649A1 (en) Oral antirheumatic compsn - of aceylsalicylic acid magnesium thiomalate, thiamine and ascorbic acid
ES354787A1 (en) Sulfur-containing derivatives of 2-methyl-4-hydroxymethyl-5-methylene-pyridine
AU3667871A (en) Prostaglandin analogs and their production
GB1126153A (en) Novel polygalacturonic acid derivative
FR2081364A1 (en) Compsn for oral calcitherapy
GB1437138A (en) Method of increasing sexual potency
FR2159195A1 (en) Compsns contg sorbitol and a corticoid or pyrazolone - - suppression of ulcerogenic effects
GB1292496A (en) Dosage units of contraceptive preparations for human use
FR2081580A1 (en) Pharmacol-active 2,4,6-trimethoxybenzoates
GB1327467A (en) Pharmaceutical compositions for inhibiting indoleamine- n-methyl transferase
GB1368251A (en) Theophylinylmethylethanoic acid ester
Laurence Basic NHS Costs Para-seltzer tablets (100)€ 1.98 Paracetamol tablets BP (100) 33p Panodol effervescent tablets (24) 23P
FR2088218A1 (en) Lactulose-cytochrome c compsns - treatment of nephropathic acidosis and auto-toxic states
GB1269616A (en) Improvements in pharmaceutical compositions
AU464180B2 (en) Orally administrable drug dosage form having delayed action
GB976096A (en) Pharmaceutical compositions
BE768809A (en) NEW MEDICINES USEFUL IN PARTICULAR FOR THE TREATMENT OF HEART DISORDERS
AU422369B2 (en) Novel way of administering insoluble medicaments
FR2244501A1 (en) 5-Chloro-3-formyl-2-methylindoles - with diuretic analgesic and antiinflammatory activity
GB1257711A (en)

Legal Events

Date Code Title Description
GC Lien (pledge) constituted
TP Transmission of property
ST Notification of lapse